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Purpose: The genetic influence on the attainment of elite athlete status is well-established, 53 
with a number of polymorphisms found to be more common in elite athletes than in the 54 
general population. As such, there is considerable interest in understanding whether this 55 
information can be utilised to identify future elite athletes. Accordingly, the aim of this study 56 
was to compare the total genotype scores of five elite athletes to those of non-athletic 57 
controls, to subsequently determine whether genetic information could discriminate between 58 
these groups, and, finally, to suggest how these findings may inform debates relating to the 59 
potential for genotyping to be used as a talent identification tool. Methods: We compared the 60 
total genotype scores for both endurance (68 genetic variants) and speed-power (48 genetic 61 
variants) elite athlete status of five elite track and field athletes, including an Olympic 62 
Champion, to those of 503 Caucasian non-athletic controls. Results: Using the speed-power 63 
total genotype score, the elite speed-power athletes scored more highly than the elite 64 
endurance athletes. However, using this speed-power score, 68 non-athletic controls 65 
registered higher scores than the elite power athletes. Surprisingly, using the endurance total 66 
genotype score, the elite speed-power athletes again scored more highly than the elite 67 
endurance athletes. Conclusions: These results suggest that genetic information is not 68 
capable of accurately discriminating between elite athletes and non-athletic controls, 69 
illustrating that the use of such information as a talent identification tool is currently 70 
unwarranted and ineffective.  71 
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Over the last thirty years, our appreciation of how genetics influences elite sports 101 
performance has grown exponentially, with previous estimates of the heritability of elite 102 
athlete status within a population reported to be approximately 66%.1  Similarly, our 103 
understanding of how specific genetic variants, such as ACTN3,2 may predispose towards 104 
elite performance has developed. Such advances have led to speculation that genetic testing 105 
may be a viable tool to identify individuals with an increased likelihood of achieving elite 106 
athlete status in the future, with some direct-to-consumer genetic testing companies already 107 
offering this service.3  108 
 109 
However, at present, the scientific consensus suggests that such approaches are 110 
ineffective at identifying future talented performers.3 Previously, Williams & Folland4 111 
incorporated 23 genetic variants associated with elite endurance performance in a data 112 
simulation, with subsequent results suggesting that there was only a 0.0005% chance of any 113 
single person in the world having the optimal form of all 23 performance-associated variants. 114 
A further issue is that, within this simulation, there was considerable similarity in polygenic 115 
profiles between individuals, with the clustered distribution of genotype scores limiting the 116 
emergence of genetic outliers, who we might reasonably predict are more likely to be elite 117 
athletes. Similar findings, relating to muscular strength and power characteristics, have also 118 
been demonstrated.5 Such issues have also been explored experimentally, most commonly via 119 
the use of Total Genotype Scores (TGS). Here, a score is assigned for each genotype of 120 
interest, and then summed into a final score for that athlete. For example, Ruiz and 121 
colleagues6 collected data on elite Spanish endurance athletes and controls. Whilst, on 122 
average, the athletes within that cohort had a greater TGS for a panel of seven endurance-123 
related polymorphisms than non-athletic controls, there was considerable overlap in score 124 
between the populations, thereby illustrating that the predictive capability of this particular 125 
TGS was low. Indeed, whilst individuals with a TGS above 74.71 were over five times more 126 
likely to be elite athletes, only 43.5% of elite athletes attained such a score. Similar results 127 
were reported for elite power athletes;7 again, the athletes had a higher average power TGS 128 
than both controls and endurance athletes, but with a large crossover of standard deviations 129 
between the groups, indicating limited sensitivity and specificity.  130 
 131 
Such evidence suggests that utilising a relatively low number of polymorphisms to 132 
identify elite athletes is unlikely to provide meaningful insights. However, many more 133 
polymorphisms than the 23 or fewer utilised in the studies to date have been associated with 134 
elite performance. A recent literature review,8 for example, reported that at least 155 genetic 135 
markers have been associated with elite athlete status, with further associations emerging 136 
since that article’s publication.9 Additionally, in a recent survey in the UK, 67% of athletes 137 
and 48% of support staff stated that genetic testing would form a valuable addition to talent 138 
identification processes within their sport,10 suggesting that there is an appetite for such 139 
information within the sports performance world.  140 
 141 
Despite this apparent enthusiasm, however, further research in this area is clearly 142 
required. Currently, it remains unclear whether genetic information can accurately 143 
discriminate between elite performers and members of the general public. In addressing this 144 
lack of evidence-led insight, within this investigation we used an expanded TGS, 145 
incorporating an increased number of genetic variants, to determine whether such a panel can 146 
reliably distinguish between a sub-population of five elite athletes and a control population of 147 
European Caucasians. To the best of our knowledge, such a large scale TGS has not 148 
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The participants were five former or current high-level athletes. All participants gave written, 155 
informed consent for their genotype results and identity to be shared here. All participants 156 
read the final version of this manuscript prior to submission, and consented to its publication, 157 
and their naming within this publication.  The study protocol was approved by the University 158 
of Central Lancashire Ethics Committee, in accordance with the Declaration of Helsinki 159 
(Ethics Board number BAHSS 575) 160 
 161 
Participant A (Andrew Steele) is a former 400m runner. He competed at one Olympic 162 
Games, winning a medal in the 4x400m relay. His personal best time is 44.94s, and he was a 163 
high-level athlete for approximately 11 years.  164 
 165 
Participant B (Greg Rutherford) is a former long jumper. He has competed at three 166 
Olympic Games, winning a Gold and a Bronze medal. His personal best distance is 8.51m, 167 
and he was a high-level athlete for approximately 13 years.  168 
 169 
Participant C (Craig Pickering) is a former sprinter. He competed at one Olympic 170 
Games, and has a World Championships Bronze medal in the 4x100m relay. His personal 171 
best 100m time is 10.14s, and he was a high-level athlete for approximately 7 years.  172 
 173 
Participant D (Tom Lancashire) is a middle-distance runner, competing primarily over 174 
1500m, the distance at which he was selected for an Olympic Games. His personal best 175 
1500m time is 3:33:96, and he was a high-level athlete for approximately 13 years.  176 
 177 
Participant E (Andrew Lemoncello) is a long-distance runner, with a Marathon 178 
personal best time of 2:13:40. He competed at two World Championships, and one Olympic 179 
Games, and was a high-level athlete for approximately 12 years.  180 
 181 
All participants are of primarily European Caucasian ethnicity, although Participant 182 
D’s mother is Mauritian.  183 
 184 
Genetic Testing 185 
Each participant volunteered a saliva sample, which was collected through sterile and 186 
self-administered buccal swabs. The samples were sent to AKESOgen, Inc (Peachtree 187 
Corners, GA, USA), where DNA was extracted from the saliva samples using Qiagen 188 
chemistry on an automated Kingfisher FLEX instrument (Thermo Fisher Scientific, 189 
Waltham, MA, US), following the manufacturer’s recommended protocols and standard 190 
operating procedures. PicoGreen and Nanodrop measurements were taken to measure the 191 
quality and quantity of the DNA. Input to the custom testing array occurred at 200ng in 192 
20µL. Amplification, fragmentation, and resuspension was performed using Biomek FXP 193 
following Affymetrix’s high throughput protocol for Axiom 2.0. Hybridization was 194 
performed for 24 hours at 48°C in a Binder oven, and staining and scanning of the arrays was 195 
performed using GeneTitan instrumentation (Thermo Fisher Scientific, Waltham, MA, US), 196 
all following the same Affymetrix high throughput Axiom 2.0 protocol. Data analysis was 197 
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then performed using a raw CEL file data input into the Affymetrix Axiom Analysis Suite 198 
(Affymetrix, Santa Clara, CA, US).  199 
 200 
Creation of Total Genotype Scores 201 
In order to best examine the potential use of genetic information in identifying elite 202 
athletes, polymorphisms previously linked to elite speed-power and elite endurance athlete 203 
status were collated through a structured literature search.  204 
 205 
Speed-Power Athlete Status: A total of 48 genetic variants associated with power 206 
athlete status were identified from two review articles.8,11 Of these 48, one marker (IL1RN) 207 
could not be genotyped due to lack of coverage on the AKESOgen chip array. A further SNP, 208 
rs2854464 in ACVR1B, was added to the panel based on subsequent research.12 Three 209 
additional SNPs in the carnosine genes CNDP1 and CNDP2, associated with elite power 210 
athlete status9 were also not present on the chip array, and so were not assessed. 211 
Mitochondrial DNA (mtDNA) was not assessed. The effect allele of one SNP, rs11091046 in 212 
AGTR2, was reversed given the findings of a recent meta-analysis.13 Accordingly, 48 genetic 213 
variants were utilised in the power TGS within this study.  214 
 215 
Endurance Athlete Status: A total of 68 genetic variants associated with endurance 216 
athlete status were identified from two review articles.8,11 Of these, the genotype of 5 217 
(ADARA2A 6.7/6,3kb, BDKRB2 +9/-9, COL5A1 rs71746744, NOS3 4A/4B, PPP3R1 5I/5D) 218 
could not be determined due to insufficient coverage. We also added rs10497520 TTN to the 219 
TGS.14 mtDNA was not assessed. Accordingly, 64 genetic variants were utilised in the 220 
endurance TGS within this study.  221 
 222 
Scoring 223 
For each genetic variant, a score of 0, 1 or 2 was given depending on the genotype of 224 
the athlete. A score of 2 represents the possession of two alleles associated with elite athlete 225 
status (e.g. CC for ACTN3 rs1815739 within the power TGS); a score of 1 represents carriage 226 
of one such allele (e.g. CT for ACTN3 rs1815739 within the power TGS); and a score of 0 227 
represents the possession of no elite athlete-associated alleles for that genetic variant (e.g. TT 228 
for ACTN3 rs1815739 within the power TGS). For each trait, the scores were then summated, 229 
divided by the total possible score, and multiplied by 100 to get a percentage. This method is 230 
identical to that utilised in previously published research utilising a TGS to explore elite 231 
athlete status.4-7 The analysis was carried out in Excel 16.13.1 (Microsoft, Redmond, WA, 232 
USA). 233 
 234 
Control Population 235 
In order to develop an adequate control population, genotype scores for 503 European 236 
Caucasians were downloaded from e!GRCh37 (http://grch37.ensembl.org/index.html) into a 237 
spreadsheet for analysis. For each genetic variant, a score of 0, 1, or 2 was given as per the 238 
speed-power and endurance TGS detailed previously. The sum of scores for each variant was 239 
then calculated, and converted into the TGS% as per the previously detailed method. 240 
Additionally, the mean and standard deviation score for this reference population were 241 




TGS Scores 246 
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Table 1 shows the results of all five participants’ speed-power TGS, as well as the 247 
mean score expected in European Caucasians. The three speed-power athletes had the highest 248 
TGS, whilst the two endurance athletes had the lowest. This trend held up in comparison to 249 
the mean score for European Caucasians, with the speed-power athletes having a higher score 250 
than the mean, and the endurance athletes a lower score than the mean. Table 1 also 251 
demonstrates the results of the endurance TGS. Here, the two endurance athletes still have 252 
the lowest TGS – lower than the elite speed-power athletes and the mean for European 253 
Caucasians.  254 
 255 
Insert Table 1 around here 256 
 257 
Comparison to previously published TGS 258 
The next stage of our analysis was to calculate the TGS from previously published 259 
research by Ruiz and colleagues.6,7 The results for both the speed-power and endurance TGS 260 
developed by Ruiz are shown in table 2.  261 
 262 
 263 
Insert Table 2 around here 264 
 265 
 266 
Non-athlete Control Results 267 
We then calculated the frequency distributions for 503 non-athletic Caucasian 268 
controls for both the power (figure 1) and endurance (figure 2) TGS. In general, the results of 269 
the controls are fairly tightly distributed around the mean. Within the power TGS, no 270 
participants fell below a score of 26%, or above a score of 53%. Similarly, within the 271 
endurance TGS, no participant had a score below 34% or above 55%. 272 
 273 
 274 
Insert Fig 1 around here 275 
 276 
 277 




Using a 48 SNP TGS of speed-power associated SNPs, we found a general trend for 282 
the elite speed-power athletes to score more highly (range 42.7-44.8%) than the elite 283 
endurance athletes (37.5%) in our cohort. The mean score for our control population of 284 
European Caucasians was 39.4%; lower than the scores achieved by the speed-power 285 
athletes, but higher than the elite endurance athletes. These outcomes may appear to 286 
provisionally support the use of genetic information to identify talented performers; however, 287 
both endurance athletes and two of the three power athletes were within one standard 288 
deviation of the non-athletes mean score. Indeed, in the 503 European reference samples 289 
utilised, 68 individuals had higher speed-power TGSs than athlete A, the highest scoring 290 
athlete in our cohort. The highest score in the control population was a TGS of 50%, just over 291 
2SDs greater than the mean.  292 
 293 
The results for the 64 SNP endurance TGS further demonstrated the lack of utility of 294 
genetic testing for talent identification. Here, all three speed-power athletes (range – 43.8-295 
47.7%) out-scored the endurance athletes (39.8 – 42.2%), who in turn scored lower than the 296 
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mean for European Caucasians (43.8%). The SD for scores in the 503 European reference 297 
samples was 3.8%, with 82 control participants having an endurance score >1SD outside of 298 
the mean. The highest score was 54.6%. 299 
 300 
The comparison to the previously published TGS utilised by Ruiz and colleagues6,7 301 
provides some interesting results. In our cohort, the elite endurance athletes scored more 302 
highly on Ruiz and colleagues’6 endurance TGS (64 and 71%) than our speed-power athletes. 303 
This is the opposite result to that seen when utilising the larger scale TGS developed for our 304 
study. This potentially suggests that the utilisation of fewer genetic variants within a TGS 305 
may enhance the predictive ability of such a model, potentially because the selected variants 306 
have a greater effect size, or that the reported effects in the literature are correct, and not 307 
spurious. Larger sample sizes are required to further test this. Regarding the power TGS , the 308 
athletes in our cohort all scored lower than the mean power score in the Ruiz and colleagues7 309 
cohort; two just outscored the mean for European Caucasians, whilst participant C—a  310 
European medalist over the 60m sprint—scored below the mean for European Caucasians, 311 
and was outscored by participant E, the long-distance runner. Again, this is in contrast to our 312 
results, where the speed-power athletes all outscored the endurance athletes, suggesting that 313 
the larger scale TGS is potentially more sensitive in determining speed-power athlete status.   314 
 315 
The two genetic variants most well-associated with elite athlete status are ACE and 316 
ACTN3.2,15,16 Regarding ACTN3, the C allele of rs1815739 is consistently associated with 317 
elite speed-power athlete status, with two recent meta-analyses17,18 finding that individuals 318 
with the TT genotype were significantly less likely to achieve elite speed-power athlete status 319 
compared to those with at least one C allele. The three speed-power athletes within our 320 
cohort exhibit the full range of ACTN3 genotypes (data not shown). Participant B, the highest 321 
achieving of our cohort, possesses the CC genotype. Participant C, the short sprinter, 322 
possesses the CT genotype, whilst Participant A, the Olympic 400m relay medallist, is a TT 323 
genotype. This latter result is somewhat surprising given that this genotype is considered 324 
unfavourable for elite speed performance, a result which has also been demonstrated in 400m 325 
runners.16 Furthermore, the endurance athletes in this cohort possessed the CT and CC 326 
genotype respectively, both of which might be considered slightly unfavourable for elite 327 
endurance performance.17 This relationship, however, appears complex and poorly 328 
understood; whilst some studies suggest an association between the ACTN3 T allele and elite 329 
endurance status2, others do not.19 330 
 331 
The genotype results for ACE were similarly heterogenous (data not shown). For this 332 
genetic variant, the D allele is considered favourable for elite speed-power athlete status,17,18 333 
with the I allele favourable for elite endurance athlete status.17 Within our speed-power 334 
cohort, two athletes had the ID genotype, and one the II genotype; neither is considered 335 
optimal for elite speed performance. Conversely, both endurance athletes had the favourable 336 
II genotype.  337 
 338 
Non-athletic controls exhibited extensive similarities in polygenic profiles, with a 339 
minimal spread of results across individuals. This similarity in polygenic profiles in non-340 
athletes has previously been reported with a lower number of generic variants for both 341 
endurance4 and strength/power5 phenotypes. Within this case study, none of the elite athletes 342 
were significant outliers in terms of TGS%, demonstrating that, for the polymorphisms 343 
tested, genetic information is not sufficient to discriminate between elite athletes and non-344 
athletic controls.  345 
 346 
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Would genetic testing have helped identify these athletes at a young age? 347 
Based on these results, it seems unlikely that genetic testing of these athletes during 348 
their teenage years would have correctly identified them as potential future elite athletes 349 
relative to a group of non-athletes. In fact, it’s unlikely that this information would have 350 
proved more useful than traditional talent identification methods. Participant A, for example, 351 
was English Schools 400m Champion at age 16. Participant B is the British under-20 Long 352 
Jump record holder and former European under-20 Champion. Participant C won multiple 353 
national age group titles at under-15 and under-17, and the European under-20 354 
Championships. Participant D won multiple junior national titles, and Participant E also won 355 
national age-group championships. Consequently, given the failure of genetic information to 356 
provide insights over and above that provided by inspecting results and observing 357 
performances, the practical utility of such tests for the specific purpose of talent identification 358 
is not supported by these case study results. In addition, the utilisation of genetic testing in 359 
under-18s is ethically troubling, with a number of key researchers recommending against 360 
such practice.3,20,21   361 
 362 
Limitations 363 
There are some limitations to the present study that must be considered when 364 
interpreting the results. Firstly, we were unable to collect data on mitochondrial DNA 365 
(mtDNA). Mitochondrial haplotypes have been associated with elite athlete status, with 366 
different variations conferring an advantage or disadvantage in achieving elite athlete status 367 
for both speed-power and endurance athletes.8,22-24 Furthermore, we were unable to collect 368 
genotype data for a small number of polymorphisms, due to a lack of coverage on the testing 369 
array. There is the potential that the athletes in this study may have held favorable versions of 370 
these variants, which would have increased their scores. Nevertheless, even given these 371 
limitations, the genotype panel created for use in this study represents the most 372 
comprehensive gene score to appear in the published literature with regards to elite athlete 373 
status. Furthermore, we utilised an unweighted TGS, with each variant having a score of 0, 1, 374 
or 2 depending on genotype. A weighted TGS, with genetic variants with demonstrably larger 375 
effect sizes getting a greater score, may have proved more accurate. However, at present, 376 
very few genetic variants associated with elite athlete status have been adequately replicated, 377 
making the development of such a weighted, multi-variant TGS difficult to achieve. 378 
 379 
In addition, the comparison population utilised within this study was an anonymous 380 
group of 503 European Caucasians. One issue with using such a group is that the identities of 381 
the participants is unknown; there is the possibility that this group was comprised of a large 382 
number of elite athletes, which would have skewed the results, although this is very unlikely. 383 
Finally, the sample sized utilised within this study is extremely limited, with further research 384 
with larger numbers of athletes required.  385 
 386 
Practical Applications 387 
 388 
It seems clear that, at present, genetic testing cannot adequately discriminate between 389 
elite athletes and non-athletes. In the current study, the TGS scores of five elite athletes did 390 
not deviate substantially from average population scores, nor did they reach the thresholds 391 
typically seen in elite athletes from other published TGS-elite athlete status associations,6,7 392 
although the number of genetic variants used within these earlier studies was very small. 393 
Indeed, within this present cohort, and utilising a larger-scale TGS, all three of the elite 394 
power athletes had a higher endurance score than both the middle-distance and long-distance 395 
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runners. As a result, it appears that current commercially available genetic tests purporting to 396 
assist in the talent identification process have minimal utility,21 and should not be used.3 397 
 398 
Athletic success is predicated on a wide variety of capacities. In the future, as a 399 
greater number of genetic variants associated with elite athlete status are identified, especially 400 
in areas involved in the psychological,25,26 anatomical,27 and skill acquisition28 aspects 401 
associated with elite athlete status, it is feasible that the predictive ability of future TGSs may 402 
improve. Such improvements could be further facilitated by the use of weighted algorithms, 403 
where genetic variants with relatively larger effect sizes achieve a higher relative score 404 
compared to variants with a smaller effect size. However, at present, and as clearly illustrated 405 
by this case study involving highly elite athletes, the similarity of polygenic profiles within 406 
populations limits the capacity of genetic information to adequately discriminate between the 407 
general population and high performing athletes. For further insights into the limitations of 408 
genetic testing for talent identification, interested readers are directed to reviews by Webborn 409 




The results of this study suggest that, at present, the ability to utilise genetic 414 
information to identify talented performers holds limited predictive utility. The reasons for 415 
this are potentially varied, but include a limited understanding of the genetic variants that 416 
predispose to elite performance, the importance of non-genetic factors in the talent 417 
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Participant A B C D E European 
Average 
Speed TGS 44.8 43.8 42.7 37.5 37.5 39.4 
Endurance 
TGS 
46.9 47.7 43.8 42.2 39.8 43.8 
 566 
Table 1 – Comparison of athletes’ scores in both the speed and endurance TGS utilised 567 
























































57.1 42.9 57.1 64.3 71.4 60.7 70.2  
 610 
Table 2 – Overview of the athletes’ scores on previously published research by Ruiz and 611 
colleagues6,7.  612 
 613 
